Can-Fite BioPharma American Depositary Shares
CANF
6 hedge funds and large institutions have $929K invested in Can-Fite BioPharma American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 6 → 6 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
29% less capital invested
Capital invested by funds: $1.3M → $929K (-$371K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.16M |
| 2 |
Morgan Stanley
New York
|
+$184K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$71.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $610K | +$1.16M | +1,059 | New |
|
|
2
Morgan Stanley
New York
| $176K | +$184K | +168 | +123% |
|
|
MIH
3
Meitav Investment House
Bene-Beraq,
Israel
| $103K | – | – | – |
|
|
TSS
4
Two Sigma Securities
New York
| $37K | +$71.3K | +65 | New |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $1.53K | – | – | – |
|
|
AF
6
Advisornet Financial
Minnetonka,
Minnesota
| $1K | – | – | – |
|
|
RJA
7
Raymond James & Associates
St Petersburg,
Florida
| – | -$12K | -5 | Closed |
|
CANF Hedge Fund Activity: Q2 2019 in Review
6 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q2 2019, worth a combined $929K — down 29% from $1.3M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CANF positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.16M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $12K sold.
- 6 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $929K of Can-Fite BioPharma American Depositary Shares stock for Q2 2019, down 29% quarter-over-quarter.
- 2 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q2 2019 and 1 closed out, a net change of +1 holder.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q2 2019 was Sabby Management, an estimated $1.16M added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q2 2019 was Raymond James & Associates, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2019.